YMR290W-A Antibody

What is YMR290W-A and why is it classified as a dubious open reading frame?

YMR290W-A is classified as a dubious open reading frame (ORF) in Saccharomyces cerevisiae (baker's yeast) because it is unlikely to encode a functional protein based on available experimental and comparative sequence data. This classification stems from genomic analysis that indicates a lack of conservation patterns typical of protein-coding genes, absence of protein detection in proteome studies, and computational predictions suggesting limited coding potential. Most importantly, YMR290W-A overlaps with the 5' end of the essential HAS1/YMR290C gene, which encodes an ATP-dependent RNA helicase that performs critical cellular functions .

How does YMR290W-A relate to growth phenotypes in experimental screens?

Despite its classification as a dubious ORF, YMR290W-A has shown significant phenotypic signatures in growth-based screening experiments. Pooled culture growth experiments reveal that yeast strains with YMR290W-A modifications exhibit varying responses to different chemical compounds. For instance, when exposed to compound 4443 at 14 μM concentration, strains showed a dramatic negative normalized phenotypic value (NPV) of -7.97, placing in the 0.58th percentile of all tested strains . This suggests substantial growth inhibition under these conditions.

Conversely, the same gene showed positive growth effects in other contexts. When exposed to compound 4464 at 199 μM, strains exhibited an NPV of 8.01, placing them in the 100th percentile . This stark contrast in phenotypic outcomes across different chemical environments suggests that either YMR290W-A itself, or more likely the genomic region it overlaps with, plays an important role in cellular responses to specific chemical stressors. These phenotypic data represent valuable starting points for researchers to investigate potential regulatory functions or indirect effects of this genomic region .

What are the specifications of commercially available YMR290W-A antibodies?

Commercial YMR290W-A antibodies are available specifically for Saccharomyces cerevisiae (strain ATCC 204508 / S288c). The antibody produced by CUSABIO (product code: CSB-PA259293XA01SVG) corresponds to UniProt accession number A0A023PZH5 and is available in two volume options: 2ml or 0.1ml . This antibody is designed for research applications in yeast biology, particularly for investigating this dubious ORF that overlaps with the essential HAS1 gene.

The antibody is specifically generated against the putative protein product of YMR290W-A, though researchers should note the dubious nature of this ORF when interpreting results. Standard validation procedures would be particularly important for this antibody given the classification of its target. The antibody is intended for research use only in laboratory settings and follows standard storage and handling protocols typical of research-grade antibodies .

How should YMR290W-A antibody be validated before experimental use?

Validation of YMR290W-A antibody requires particular rigor due to the dubious nature of its target. Begin with Western blot analysis using wild-type yeast extract alongside a control from a YMR290W-A deletion strain (if viable) or a strain with epitope-tagged YMR290W-A. Since YMR290W-A overlaps with HAS1/YMR290C, it's crucial to distinguish signals originating from each potential protein . Implement peptide competition assays using the immunizing peptide to confirm specificity, observing signal reduction when the antibody is pre-incubated with excess peptide.

Immunoprecipitation followed by mass spectrometry can help identify all proteins captured by the antibody, critical for determining any cross-reactivity with HAS1/YMR290C products. Additionally, immunofluorescence microscopy comparing staining patterns in wild-type and control strains can provide spatial context for any detected signals. Given that YMR290W-A is considered unlikely to encode a functional protein, negative results should be interpreted carefully and may actually be consistent with its dubious classification . Document all validation steps meticulously, as they will be essential for accurately interpreting experimental outcomes and addressing reviewer questions about antibody specificity.

What experimental controls are essential when using YMR290W-A antibody?

When working with YMR290W-A antibody, implementing comprehensive controls is critical due to the dubious nature of this ORF. Always include a negative control from a YMR290W-A deletion strain (if viable, considering its overlap with essential HAS1/YMR290C). Since gene deletion might affect HAS1 expression, creating a strain with a frameshift or early stop codon in YMR290W-A that doesn't affect HAS1 function would provide a more precise negative control .

Positive controls are challenging given the dubious status, but a strain overexpressing YMR290W-A under a strong promoter can serve this purpose. Include a loading control targeting an abundant, stable protein such as actin to normalize signal intensity across samples. For experiments investigating the relationship between YMR290W-A and HAS1, controls examining HAS1 expression independently are essential. Additionally, use secondary antibody-only controls to identify non-specific binding, and pre-immune serum controls if available . When conducting growth phenotype studies related to YMR290W-A, always include wild-type strains grown under identical conditions with the same compound concentrations to establish proper baselines, particularly for compounds that showed extreme phenotypic values in previous screens.

How can researchers optimize detection of YMR290W-A in growth phenotype studies?

Optimizing detection of YMR290W-A effects in growth phenotype studies requires attention to both experimental design and analytical approaches. Begin by selecting chemical compounds that previously showed strong phenotypic signatures with YMR290W-A, such as compound 4443 (NPV -7.97), compound 4462 (NPV -4.09), and compound 4464 (NPV 8.01) . Establish concentration gradients around the reported values to capture the full response curve rather than testing only a single concentration.

Implement both pooled and individual culture growth assays to differentiate between community effects and direct phenotypic impacts. Use high-resolution growth monitoring systems that capture data at frequent intervals (e.g., every 15 minutes) to detect subtle growth differences that might be missed in endpoint measurements. For pooled culture experiments, employ barcode sequencing techniques similar to those used in the Hoepfner and Movva studies to accurately quantify strain abundance changes over time .

Normalize data meticulously using multiple reference strains to control for batch effects and technical variability. Calculate both absolute growth rates and competitive fitness indices to comprehensively assess phenotypic impacts. Given YMR290W-A's overlap with HAS1, parallel experiments with strains modified to affect HAS1 expression without altering the YMR290W-A sequence will help distinguish the genetic source of any observed phenotypes. Finally, implement cross-validation approaches and biological replicates to ensure reproducibility of phenotypic signatures across independent experiments.

How can YMR290W-A antibody be used to study overlapping gene regions?

YMR290W-A antibody provides a valuable tool for investigating overlapping gene architecture, particularly because YMR290W-A overlaps with the 5' region of the essential HAS1/YMR290C gene . To effectively study this genomic arrangement, researchers can employ chromatin immunoprecipitation followed by sequencing (ChIP-seq) using both YMR290W-A and HAS1 antibodies to map the precise binding patterns and potential regulatory interactions at this locus. This approach can reveal whether transcription factors or chromatin remodelers differentially associate with these overlapping regions.

RNA immunoprecipitation (RIP) can identify any RNA species produced from the YMR290W-A locus and determine whether they interact with HAS1 protein or other factors, potentially revealing regulatory RNA functions even without protein production. For mechanistic studies, CRISPR-based approaches that introduce specific mutations affecting YMR290W-A without disrupting HAS1 function can help dissect the functional relationship between these overlapping genes . Create reporter constructs containing the overlapping region with fluorescent tags for each reading frame to visualize expression patterns of both genes simultaneously in single cells across different conditions.

Combined with the growth phenotype data showing condition-specific responses (such as the dramatic NPV values with compounds 4443, 4462, and 4464), these approaches can elucidate whether genomic overlap contributes to coordinated regulation or represents an example of genomic economy where seemingly non-functional sequences may serve regulatory purposes . This research direction has broader implications for understanding genome evolution and organization in eukaryotes.

What approaches can verify if YMR290W-A actually produces a protein despite its dubious status?

Verifying protein production from YMR290W-A despite its dubious classification requires a multi-faceted approach. Begin with ribosome profiling (Ribo-seq) to detect ribosome occupancy specifically on the YMR290W-A transcript, which would indicate active translation. This technique can distinguish translation patterns between YMR290W-A and the overlapping HAS1 gene . Complement this with polysome profiling followed by targeted RT-PCR to determine whether YMR290W-A mRNA associates with actively translating ribosomes.

Employ mass spectrometry-based proteomics with high sensitivity settings, focusing on detection of peptides unique to the predicted YMR290W-A sequence. To increase detection probability, analyze samples from conditions where YMR290W-A showed extreme phenotypic values, such as in presence of compounds 4443 (NPV -7.97) or 4464 (NPV 8.01) . Generate strains with epitope-tagged YMR290W-A, ensuring tags don't disrupt HAS1 function, and conduct targeted immunoprecipitation with subsequent Western blotting using highly sensitive detection methods.

Utilize in vitro translation systems with YMR290W-A transcript to test whether the sequence can be translated in a controlled environment. Additionally, create reporter constructs fusing the YMR290W-A coding sequence with fluorescent proteins to visualize potential expression in vivo. Since dubious ORFs might produce proteins under specific stress conditions rather than during normal growth, systematically test protein production across diverse environmental conditions, particularly those that showed phenotypic signatures in previous screens . These comprehensive approaches will help resolve whether YMR290W-A produces any protein product despite its classification as a dubious ORF.

How can researchers investigate potential regulatory roles of YMR290W-A DNA/RNA without protein expression?

Investigating the potential regulatory roles of YMR290W-A at the DNA or RNA level, independent of protein expression, requires approaches that focus on nucleic acid function. Begin with chromatin structure analysis using techniques like ATAC-seq or DNase-seq to determine if the YMR290W-A locus contains important chromatin features that might influence the expression of neighboring genes, particularly HAS1/YMR290C which it overlaps . Use CRISPRi targeting specific regions within YMR290W-A to investigate whether the DNA sequence itself contains regulatory elements affecting nearby gene expression.

Perform comprehensive transcriptome analysis (RNA-seq) in strains with modified YMR290W-A sequences that preserve the HAS1 coding potential to detect any trans-regulatory effects on the yeast transcriptome. This can reveal whether the YMR290W-A locus produces non-coding RNAs with regulatory functions . Employ RNA structure probing techniques (SHAPE-seq, DMS-seq) to determine if transcripts from this region form functional secondary structures that might interact with cellular machinery.

Conduct RNA pulldown assays using YMR290W-A transcripts as bait to identify interacting proteins or other nucleic acids that might suggest regulatory roles. RNA immunoprecipitation (RIP) with RNA-binding proteins can detect whether YMR290W-A transcripts associate with specific regulatory complexes. Additionally, examine the conservation pattern of the YMR290W-A sequence across related yeast species to identify conserved elements that might indicate functional importance despite the lack of protein-coding potential . These approaches can uncover potential regulatory functions of YMR290W-A that explain the significant phenotypic signatures observed in chemical genetic screens without invoking protein production from this dubious ORF .

How should researchers interpret conflicting results involving YMR290W-A detection?

When confronting conflicting results in YMR290W-A detection experiments, researchers should systematically evaluate multiple factors that could explain the discrepancies. First, assess antibody specificity through comprehensive validation studies, determining whether signals might represent cross-reactivity with the overlapping HAS1/YMR290C protein rather than YMR290W-A itself . Consider that detection might be condition-dependent, as YMR290W-A shows dramatically different phenotypic signatures across various chemical treatments (e.g., NPV ranging from -7.97 with compound 4443 to 8.01 with compound 4464) .

Examine experimental differences in sample preparation, particularly in protein extraction methods that might differently preserve or disrupt certain protein complexes or modifications. Evaluate detection thresholds across different techniques, as YMR290W-A protein might exist at extremely low abundance requiring highly sensitive methods. Additionally, consider temporal factors, as expression might be transient or cell-cycle dependent .

The dubious classification of YMR290W-A creates a unique interpretive framework where negative results align with genomic annotations while positive detection requires exceptional evidence. When positive detection occurs, critically evaluate whether the signal represents: (1) actual YMR290W-A protein despite its dubious status, (2) cross-reactivity with HAS1 or other proteins, (3) condition-specific expression not captured in previous studies, or (4) technical artifacts . Document all experimental conditions meticulously to allow proper comparison across studies, and consider that the "truth" might involve complex regulatory mechanisms where YMR290W-A DNA/RNA has function even without substantial protein production.

How can growth phenotypes associated with YMR290W-A be properly analyzed?

Analyzing growth phenotypes associated with YMR290W-A requires sophisticated approaches that account for its dubious ORF status and overlap with HAS1. Begin by transforming raw growth data into normalized phenotypic values (NPVs) as seen in the Hoepfner and Movva studies, where YMR290W-A showed both strong negative (NPV -7.97 with compound 4443) and positive (NPV 8.01 with compound 4464) phenotypes . Calculate Z-scores and percentile rankings to contextualize results within the broader distribution of all strains tested under identical conditions.

Implement time-series analysis rather than endpoint measurements to capture growth dynamics, as effects might be transient or manifest only during specific growth phases. Perform principal component analysis (PCA) or hierarchical clustering to identify patterns across multiple compounds and conditions, potentially revealing functional clusters that suggest mechanisms of action. Since YMR290W-A overlaps with HAS1, conduct parallel analyses with HAS1 mutants and compare phenotypic signatures to distinguish effects stemming from each gene .

Develop computational models that integrate growth phenotypes with transcriptomic, proteomic, and metabolomic data to build comprehensive phenotypic profiles. Apply chemical-genetic interaction mapping to place YMR290W-A in functional networks based on similarity of phenotypic signatures across chemical space. When analyzing extreme phenotypes like those observed with compounds 4443 and 4464, implement dose-response studies to establish EC50 values and quantify the relationship between compound concentration and phenotypic severity . Finally, perform epistasis analysis with mutations in functionally related genes to determine whether YMR290W-A acts in known pathways or represents a novel functional module.

What statistical approaches are appropriate for analyzing YMR290W-A expression data?

Statistical analysis of YMR290W-A expression data requires specialized approaches due to its unique genomic context as a dubious ORF overlapping with HAS1. Begin with normalization methods that account for the overlapping gene structure, employing algorithms specifically designed for resolving expression from overlapping transcripts. When analyzing RNA-seq data, implement computational approaches like Cufflinks or RSEM that can handle reads mapping to multiple features .

For differential expression analysis, employ models that account for the correlation structure between YMR290W-A and HAS1 expression, such as multivariate linear models or Bayesian approaches that can incorporate the biological relationship as prior information. Use permutation-based significance testing rather than parametric approaches when data distributions don't meet standard assumptions. Implement robust regression methods that are less sensitive to outliers, particularly important when analyzing phenotypic data where YMR290W-A showed extreme values under specific conditions (e.g., NPVs ranging from -7.97 to 8.01) .

How can specificity issues with YMR290W-A antibody be addressed?

Addressing specificity issues with YMR290W-A antibody requires comprehensive validation strategies tailored to this dubious ORF's unique challenges. Begin by generating epitope-tagged versions of both YMR290W-A and HAS1/YMR290C to create reference standards for assessing antibody cross-reactivity. Perform Western blots with these tagged strains alongside wild-type controls to map precise binding profiles . Consider developing monoclonal antibodies targeting unique epitopes in YMR290W-A that don't exist in HAS1, or use peptide arrays to identify antibody binding sites with high resolution.

Implement peptide competition assays with synthetic peptides derived from both YMR290W-A and HAS1 sequences to quantify relative binding affinities and identify potential cross-reactivity. For critical experiments, employ orthogonal detection methods that don't rely on antibodies, such as MS-based proteomics or CRISPR epitope tagging, to corroborate antibody-based findings . Pre-absorb antibody preparations against lysates from strains with YMR290W-A deletions to deplete cross-reactive antibodies.

Consider using antibody fragments (Fab) or recombinant antibodies with engineered specificity when conventional antibodies show cross-reactivity issues. Develop rigorous positive and negative controls for each experimental application, including strains with graduated expression levels of YMR290W-A. Finally, implement computational approaches to model potential cross-reactive epitopes between YMR290W-A and HAS1, guiding epitope selection for future antibody development . These comprehensive approaches will help ensure that signals detected using YMR290W-A antibody genuinely reflect the target rather than the overlapping essential gene HAS1.

What alternatives exist when YMR290W-A antibody yields inconsistent results?

When YMR290W-A antibody produces inconsistent results, researchers have several alternative approaches to investigate this dubious ORF. One robust strategy is to implement nucleic acid-based detection methods such as single-molecule FISH (smFISH) to visualize YMR290W-A transcripts with high sensitivity and spatial resolution. This approach can be complemented with RNA-seq using strand-specific protocols to precisely distinguish YMR290W-A transcripts from the overlapping HAS1 gene .

Genetic tagging offers another powerful alternative. Engineer strains with epitope tags (FLAG, HA, GFP) fused to YMR290W-A, ensuring the modifications don't disrupt HAS1 function. These tags can be detected using well-characterized commercial antibodies with established specificity. For functional studies, bypass antibody detection entirely by using phenotypic profiling approaches. Expand upon the existing chemical-genetic interaction data that shows strong phenotypic signatures for YMR290W-A (e.g., NPVs ranging from -7.97 to 8.01 with different compounds) .

CRISPR-based approaches provide yet another alternative. Implement CRISPR interference (CRISPRi) or CRISPR activation (CRISPRa) to modulate YMR290W-A expression without relying on antibody detection. Additionally, develop proximity labeling methods using BioID or APEX2 fused to proteins suspected to interact with potential YMR290W-A products. These techniques label neighboring proteins, allowing pull-down and mass spectrometry identification without requiring direct YMR290W-A antibody detection . Finally, consider comparative genomics approaches that examine conservation patterns of the YMR290W-A sequence across yeast species to infer functional importance despite its dubious classification .

What experimental designs can differentiate between YMR290W-A and HAS1/YMR290C effects?

Differentiating between effects attributed to YMR290W-A versus the overlapping HAS1/YMR290C gene requires sophisticated experimental designs that selectively manipulate each genetic element. Implement CRISPR-based strategies to introduce silent mutations in HAS1 that disrupt the YMR290W-A coding sequence without affecting HAS1 protein. Conversely, engineer mutations that create premature stop codons in YMR290W-A while preserving HAS1 function through synonymous mutations . These complementary approaches allow attribution of phenotypes to specific genetic elements.

Develop a dual-reporter system with different fluorescent proteins fused to YMR290W-A and HAS1, allowing simultaneous visualization of expression from both reading frames in single cells. This system can reveal condition-specific regulation patterns unique to each gene. Conduct RNA interference experiments with siRNAs specifically designed to target unique regions of YMR290W-A transcripts without affecting HAS1, although the overlapping nature makes this challenging .

Employ ribosome profiling to distinguish translation events in each reading frame, providing evidence for active translation of YMR290W-A despite its dubious status. Design genetic complementation experiments where YMR290W-A and HAS1 are separated and expressed from different loci, allowing assessment of their independent contributions to phenotypes. Apply these approaches when investigating the striking phenotypic responses observed with various compounds, such as the extreme negative (NPV -7.97 with compound 4443) and positive (NPV 8.01 with compound 4464) growth effects . Finally, use comparative genomics to identify yeast species where these genes don't overlap, providing natural systems for studying their independent functions .

How might YMR290W-A research contribute to understanding dubious ORFs in yeast?

YMR290W-A research offers a compelling case study for understanding the broader significance of dubious ORFs in yeast genomics. Despite its classification as unlikely to encode a functional protein, YMR290W-A exhibits striking phenotypic signatures in chemical genetic screens, with normalized phenotypic values ranging from -7.97 to 8.01 in different conditions . This dramatic range of responses challenges conventional assumptions about dubious ORFs and suggests they may contribute to cellular phenotypes through mechanisms beyond protein coding.

Systematic investigation of YMR290W-A could establish methodological frameworks for studying other dubious ORFs, particularly those overlapping with essential genes like HAS1. By developing techniques that distinguish effects of overlapping genetic elements, researchers can create a roadmap for functional genomics of complex loci . Additionally, YMR290W-A research may reveal whether dubious ORFs serve as regulatory elements affecting neighboring gene expression or produce non-coding RNAs with functional roles.

The availability of commercial antibodies for YMR290W-A (e.g., CSB-PA259293XA01SVG) enables protein-level studies that might reveal whether some dubious ORFs produce proteins under specific conditions not captured in previous proteomics studies . Comparative genomics approaches examining YMR290W-A conservation across yeast species could establish whether seemingly non-functional ORFs are maintained through selection despite their dubious classification . Together, these investigations could fundamentally reshape our understanding of genome annotation, potentially revealing that dubious ORFs represent an underappreciated layer of genomic functionality with significant phenotypic consequences.

What integrative approaches could reveal new insights about YMR290W-A function?

Revealing new insights about YMR290W-A function requires integrative approaches that combine multiple data types and experimental paradigms. Develop systems biology frameworks that integrate chemical-genetic interaction profiles (where YMR290W-A shows extreme NPVs ranging from -7.97 to 8.01) with transcriptomics, proteomics, and metabolomics data across matching conditions. This multi-omics integration can identify molecular pathways affected by YMR290W-A perturbation even without direct protein function.

Implement network analysis approaches that place YMR290W-A in the context of genetic and protein interaction networks, potentially revealing functional associations not evident from direct experiments. Combine structural biology techniques with evolutionary sequence analysis to determine whether YMR290W-A, despite its dubious classification, contains conserved structural elements that might indicate function .

Develop machine learning models trained on known gene functions to predict potential roles for YMR290W-A based on its phenotypic signatures across chemical space. These computational predictions can guide targeted experimental validation. Create single-cell multi-modal assays that simultaneously measure transcription, translation, and phenotypic outcomes in individual cells with YMR290W-A modifications, revealing population heterogeneity that might be masked in bulk experiments .